Can colchicine response be predicted in familial Mediterranean fever patients?

Rheumatology (United Kingdom)

Volumn 53, Issue 10, 2014, Pages 1767-1772

  Özçakar, Zeynep Birsin ^a   Elhan, Atilla H ^b   Yalçinkaya, Fatoş ^a  

^a Division of Pediatric Nephrology   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Colchicine; Familial mediterranean fever; Paediatric

Indexed keywords

ACUTE PHASE PROTEIN; COLCHICINE; CYTOSKELETON PROTEIN; MARENOSTRIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTHRALGIA; ARTHRITIS; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY ASSESSMENT; ERYSIPELAS; ERYTHEMA; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FEVER; GENE; GENE MUTATION; HEEL PAIN; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LEG PAIN; MAJOR CLINICAL STUDY; MALE; MEFV GENE; MYALGIA; PATIENT COMPLIANCE; PREDICTIVE VALUE; PRIORITY JOURNAL; SCORING SYSTEM; THORAX PAIN; TREATMENT DURATION; TREATMENT RESPONSE; VASCULITIS; GENETICS; GENOTYPE; PHENOTYPE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COLCHICINE; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENOTYPE; HUMANS; MALE; PHENOTYPE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84924843751     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu138     Document Type: Article

References (20)

1. Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med 2007;65:318-24.
2. Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med 1972;287:1302.
3. Özkan E, Oku O, Ekmekçi A, Ozcan R, Tag T. A new approach to the treatment of periodic fever. Med Bull I? stanbul 1972;5:44-9.
4. Livneh A, Langevitz P, Zemer D et al. The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996; 26:612-27.
5. Ben-Chetrit E, Levy M. Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years. Semin Arthritis Rheum 1991;20:241-6.
6. Zemer D, Livneh A, Danon YL, Pras M, Sohar E. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 1991;34:973-7.
7. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. International FMF Consortium. Cell 1997;90:797-807.
8. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997;17:25-31.
9. Lidar M, Yonath H, Shechter N et al. Incomplete response to colchicine in M694V homozygote FMF patients. Autoimmun Rev 2012;12:72-6.
10. Soylemezoğlu O, Arga M, Fidan K et al. Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for M694V mutation. J Rheumatol 2010;37:182-9.
11. Yalçinkaya F, Özen S, Özçakar ZB et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology 2009;48:395-8.
12. Livneh A, Langevitz P, Zemer D et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879-85.
13. Pras E, Livneh A, Balow JE Jr et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 1998;75: 216-9.
14. Mor A, Shinar Y, Zaks N et al. Evaluation of disease severity in familial Mediterranean fever. Semin Arthritis Rheum 2005;35:57-64.
15. Aksentijevich I, Torosyan Y, Samuels J et al. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999;64: 949-62.
16. Yilmaz E, Ozen S, Balci B et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001;9:553-5.
17. Yalcinkaya F, Ozcakar ZB, Tanyildiz M, Elhan AH. Familial Mediterranean fever in small children in Turkey. Clin Exp Rheumatol 2011;29:87-90.
18. Ozçakar ZB, Yalçinkaya F, Yüksel S, Ekim M. The expanded clinical spectrum of familial Mediterranean fever. Clin Rheumatol 2007;26:1557-60.
19. Lidar M, Scherrmann JM, Shinar Y et al. Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum 2004;33:273-82.
20. Touitou I, Sarkisian T, Medlej-Hashim M et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 2007;56: 1706-12.